Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

Reshma L Mahtani,1 Monika Parisi,2 Stefan Glück,3 Quanhong Ni,2 Siyeon Park,4 Corey Pelletier,2 Claudio Faria,2 Fadi Braiteh5,6 1Division of Hematology/Oncology, University of Miami, Miami, FL, 2Health Economics and Outcomes Research, Celgene Corporation, Summit, NJ, 3Global Medical Affairs...

Full description

Bibliographic Details
Main Authors: Mahtani RL, Parisi M, Glück S, Ni Q, Park S, Pelletier C, Faria C, Braiteh F
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:Cancer Management and Research
Subjects:
Metastatic breast cancer
nab-paclitaxel
paclitaxel
hormone receptor positive
triple negative
Online Access:https://www.dovepress.com/comparative-effectiveness-of-early-line-nab-paclitaxel-vs-paclitaxel-i-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/comparative-effectiveness-of-early-line-nab-paclitaxel-vs-paclitaxel-i-peer-reviewed-article-CMAR

Similar Items